Medical devices rarely attract the same public attention as medicines, yet their reliability plays a vital role in patient care. Healthcare systems use disposable syringes, intravenous infusion sets, and other hospital consumables, making manufacturing quality and regulatory oversight essential.
Surgi Plast is a Pakistan-based medical-device manufacturer associated with disposable syringes and intravenous equipment. Its manufacturing location is documented in Gadoon Amazai, District Swabi, Khyber Pakhtunkhwa. The company’s name appears in official records maintained by Pakistan’s Drug Regulatory Authority (DRAP), particularly in connection with its Clinic-branded syringes.
The manufacturer has also drawn attention after several regulatory safety alerts in 2026 involving specific syringe batches. These developments make it necessary to examine both the company’s established manufacturing activities and the regulatory findings affecting certain products.
This article explores the company’s background, products, manufacturing operations, regulatory history, patient safety considerations, and the facts that distinguish it from similarly named businesses.
What Is Surgi Plast?
Surgi Plast is a medical-device manufacturing business operating in Pakistan’s healthcare supply sector. Unlike a hospital or pharmaceutical company developing medicines, its documented manufacturing activities focus on equipment used to deliver medical care.
The company’s products are primarily used for injections and intravenous fluid administration. These devices serve practical purposes in healthcare settings, where sterility, reliable construction, and proper usage are critical.
Official DRAP establishment records identify manufacturing sections for syringes and IV sets under reference ELM-0030. Separate medical-device registration records connect the business with Clinic auto-disable syringes in several capacities.
This documented regulatory presence provides a foundation for understanding the company. Rather than depending on promotional claims about commercial success, a more reliable assessment examines product registrations, manufacturing facilities, laboratory findings, and official safety notices.
Understanding the Company’s Background and Development
Early History and Manufacturing Location
Commercial business directories describe Surgi Plast as having been established in 2006. This date appears in historical supplier listings, although it should be treated as directory-reported information rather than independently confirmed corporate registration history.
The company’s manufacturing address is considerably better documented. DRAP records identify its premises at Plot No. 78, Road No. L-4, Industrial Estate, Gadoon Amazai, Khyber Pakhtunkhwa.
Gadoon Amazai is an industrial area in District Swabi. Locating medical-device manufacturing within an industrial estate provides a distinct operational setting from hospitals, pharmacies, and retail outlets.
For any medical manufacturer, a documented production address matters because regulators must identify the establishment responsible for specific devices. Manufacturing-site records also help distinguish products supplied by one business from those associated with another.
The Development of Its Medical Product Portfolio
The strongest evidence of the company’s product development comes from official medical-device records.
DRAP’s local manufacturer registration list identifies Clinic auto-disable syringes in 2 mL, 3 mL, and 5 mL capacities, registered on March 31, 2021 under reference MDMR-000115.
A later record identifies Clinic disposable 20 mL syringes with specified needle gauges, registered on February 21, 2023 under MDMR-000227.
These entries show that the manufacturer’s documented product portfolio extends beyond a single syringe design. They also demonstrate why company-level descriptions should be supported by product-specific information rather than broad statements about the entire business.
Products and Their Medical Applications
Disposable Syringes and Injection Equipment
Disposable syringes are among the most familiar medical devices. Healthcare professionals use them to administer injections, measure injectable fluids, and withdraw certain fluid samples when clinically appropriate.
Surgi Plast offers disposable syringe products under the Clinic brand. Public registrations identify particular capacities and needle configurations, demonstrating the importance of matching a device to its intended medical purpose.
A syringe’s capacity describes the volume it can hold, while a needle’s gauge relates to its diameter. These specifications are not interchangeable; select based on the applicable clinical procedure and product instructions.
Single-use syringes must never be reused. Changing the needle does not make a previously used syringe safe for another patient.
Auto-Disable Syringes and Infection Prevention
Auto-disable syringes are designed with mechanisms intended to prevent reuse after their designated operation. They are especially relevant in healthcare settings where preventing transmission of blood-borne infections is essential.
The Clinic auto-disable syringes documented in DRAP’s registration list include 2 mL, 3 mL, and 5 mL versions.
Their purpose illustrates an important principle of medical-device design: patient safety depends not only on whether a product delivers a fluid successfully but also on whether its safety features perform as intended.
A device marketed to prevent reuse must reliably meet its applicable performance requirements. If the mechanism fails, the design’s expected protection may not be achieved.
Intravenous Infusion Sets and Other Supplies
Official manufacturing-establishment records also identify an IV-set section at the company’s registered production location.
Intravenous infusion sets are used to deliver prescribed fluids or medications through an appropriate intravenous access device. Their components must be compatible with the intended application, and sterile fluid pathways must be protected from contamination.
Historical commercial profiles additionally associate the business with IV cannulas. However, check individual products and their current regulatory status separately rather than assuming it from an older supplier catalog.
These products demonstrate the broader importance of reliable disposable equipment in hospitals, clinics, and other supervised healthcare environments.
The Clinic Brand and Regulatory Registration
Why Product Registration Matters
Clinic is the product name appearing in multiple official records associated with the manufacturer. Its presence in DRAP documentation allows us to link specific syringe types to the registered manufacturing establishment.
Two particularly relevant historical registration entries are:
- MDMR-000115: Clinic Auto Disable Syringes, 2 mL, 3 mL, and 5 mL, issued March 31, 2021.
- MDMR-000227: Clinic Disposable Syringe, 20 mL, with specified 21G and 22G needle variants, issued February 21, 2023.
A registration entry confirms that a product appeared in the regulator’s documented registration system at the stated time. It does not independently establish the present quality of every manufactured batch or guarantee that regulatory conditions remain unchanged.
For purchasing departments, distinguishing between historical registration and current product compliance is essential.
Manufacturing Standards and Quality Control
What Reliable Medical-Device Production Requires
Manufacturing medical devices involves more than producing plastic components. Depending on the device, production controls may include raw-material evaluation, component assembly, dimensional checks, packaging integrity, sterilization validation, and finished-product testing.
For sterile syringes, the integrity of the sterile barrier and the effectiveness of the validated manufacturing process are especially important.
Auto-disable products require additional attention to their reuse-prevention mechanisms. A syringe can appear physically intact while failing an essential functional test.
Older supplier directories describe Surgi Plast as holding specific quality certifications, but historical directory claims do not establish the current validity of those certifications. Any current certification should be checked against an authentic, valid certificate and its issuing organization.
Regulatory Oversight and the 2026 Safety Alerts
May and June 2026: Auto-Disable Syringe Findings
Regulatory scrutiny became a significant part of the manufacturer’s public record in 2026.
A DRAP notice dated May 22, 2026 identified two Clinic 3 mL auto-disable syringe batches associated with Surgi Plast Industries: 3-01C-26 and 3-01B-26. These were reported as substandard after failing self-destruct performance or auto-disable testing.
A subsequent DRAP recall alert dated June 8, 2026 again identified batch 3-01B-26, describing a failure of its reuse-prevention feature.
This failure matters because an auto-disable syringe is specifically intended to prevent reuse. DRAP explained that defective reuse-prevention mechanisms could increase the risk of transmitting infections, including hepatitis B, hepatitis C, and HIV, if syringes were reused.
The notices concerned specified batches. They should not be interpreted as proof that every product the company manufactured failed testing.
October 2026: Sterility and Labeling Concerns
On October 20, 2026, DRAP published a separate recall alert concerning Clinic Disposable Syringes 20 mL, batch 20-01G-25, associated with Surgi Plast.
The notice identified two problems. The tested sample was declared substandard following sterility testing, and it was described as misbranded because the label mentioned two different needle gauges.
Sterility failure is particularly serious for a device intended for invasive medical use, since contamination can introduce microorganisms into the body. Conflicting needle-gauge information can also create confusion when selecting a suitable device.
The October notice listed an action date of June 8, 2026, even though it was published in October. These two dates should not be confused.
DRAP directed relevant authorities to identify and remove affected stock and instructed supply-chain participants to initiate appropriate recall measures.
Patient Safety and Responsible Procurement
How Healthcare Facilities Should Assess Products
For hospitals, clinics, and pharmacies, the relevant question is not simply whether a manufacturer appears in official records. The key question is whether the exact product and batch are suitable and legally available for use.
Procurement teams should establish product identity, verify applicable registration information, inspect packaging, confirm storage requirements, and review current regulatory notices.
Batch numbers are especially important because recalls frequently identify particular production lots rather than an entire manufacturer’s catalog.
Remove any product matching a recalled batch from use and handle it according to regulatory directions. DRAP has instructed affected supply-chain participants to stop supplying identified batches, quarantine remaining stock, and arrange returns through the relevant channels.
Anyone who believes they may have used an affected product should contact a qualified healthcare professional and report the concern through appropriate regulatory procedures.
Business Reputation and Public Transparency
Separating Verified Records From Promotional Claims
Historical supplier directories describe Surgi Plast as a substantial participant in Pakistan’s medical-device market. Some older profiles include ambitious market-share estimates.
These figures should not be presented as facts without supporting independent market research. The same caution applies to historical employee counts, estimated revenue, and ownership descriptions.
More dependable evidence includes the company’s documented manufacturing address, device registrations, establishment reference, and official regulatory notices.
For a business manufacturing devices that come into contact with patients, transparency matters most. Accurate product documentation, accessible regulatory information, clear labeling, and effective responses to safety concerns help buyers make informed decisions.
Public confidence ultimately depends on evidence of consistent compliance rather than promotional language.
Future Prospects and Industry Significance
The Importance of Safe Domestic Manufacturing
Medical-device manufacturing contributes to healthcare infrastructure by supplying equipment used in everyday clinical practice.
Domestic production can support local procurement opportunities and technical manufacturing expertise. However, these general industry benefits should not be confused with verified claims about any one company’s current output, employment, or market position.
For Surgi Plast, the public record documents its manufacturing history and specific regulatory challenges.
Its future standing will depend on factors that can be assessed through evidence: product quality, compliance with applicable regulations, effective corrective action, and confidence among healthcare purchasers.
The company’s case also illustrates a wider lesson for the medical-device industry. Reliable safety mechanisms and sterilization controls are indispensable, regardless of how familiar a product label may be.
Conclusion
Surgi Plast represents a documented part of Pakistan’s medical-device manufacturing sector. Its Gadoon Amazai establishment, association with Clinic-branded syringes, and registration history demonstrate its involvement in disposable injection and infusion equipment.
The company’s public record also contains significant safety findings. In 2026, DRAP identified specified Clinic syringe batches with problems involving reuse-prevention performance, sterility, and labeling.
Those findings deserve careful attention, but they don’t support claims about every device the manufacturer sells.
The most reliable way to understand this business is to assess its records objectively, distinguish historical registration information from current regulatory status, and prioritize patient safety over marketing claims.
For healthcare providers, distributors, and consumers, the central lesson is clear: medical-device quality must be evaluated through verified documentation, current safety notices, and responsible professional handling.
(FAQs)
1. What is Surgi Plast?
Surgi Plast is a Pakistani manufacturer associated with disposable medical devices, particularly syringes and intravenous equipment.
2. Where is Surgi Plast located?
Its documented manufacturing address is Plot No. 78, Road No. L-4, Industrial Estate, Gadoon Amazai, District Swabi, Khyber Pakhtunkhwa, Pakistan.
3. What products does Surgi Plast manufacture?
Official records identify syringe and IV-set manufacturing sections. The company is also associated with Clinic disposable and auto-disable syringes.
4. What is the Clinic syringe brand?
Clinic is a product name appearing in DRAP medical-device registration and recall records connected with Surgi Plast.
5. Is Surgi Plast registered with DRAP?
DRAP records identify the manufacturing establishment under ELM-0030 and show historical registrations for specific Clinic syringes. Current status must be confirmed through updated regulatory information.
6. Were any Surgi Plast products recalled in 2026?
Yes. DRAP published alerts identifying specific Clinic syringe batches, including 3-01B-26, 3-01C-26, and 20-01G-25, following laboratory findings.
7. Does a batch recall mean all Surgi Plast syringes are unsafe?
No. The identified notices concern particular products and batches. The findings should not automatically be extended to the company’s entire product range.
8. How can buyers check Surgi Plast medical-device safety?
Buyers should check the exact product name, batch number, applicable registration details, packaging condition, and current DRAP safety notices before procurement or use.
